Chronic Inflammatory Demyelinating Polyneuropathy Treatment Market Growth Analysis to 2026
Increasing drug approvals by regulatory authorities is expected to boost the global chronic inflammatory demyelinating polyneuropathy (CIDP) treatment market growth.
